companydata.dkcompanydata.dk

ZEALAND PHARMA A/S: Financial statements 2018

CVR: 20045078

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 37,977,000 and a net result of DKK 581,282,000 compared with DKK -272,271,000 the year before. That is a decrease of 72.8% compared with the year before. The profit margin was 1,530.6%. Equity in the 2018 report amounted to DKK 1,116,281,000. The solvency ratio was 90.8%.

Revenue
DKK 37,977,000
Profit/Loss
DKK 581,282,000
Equity
DKK 1,116,281,000
Total Assets
DKK 1,229,797,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201838M-581.3M1.1B-
2017139.8M--272.3M528.5M-
2016234.8M--153.9M278.2M-
2015187.7M165.4M-114M252.2M-
2014153.8M140M-65M252.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

ZEALAND PHARMA A/S publishes interim reportNov 16, 2018

ZEALAND PHARMA A/S has published its interim report for the period July 1, 2018 to September 30, 2018.

ZEALAND PHARMA A/S publishes interim reportAug 17, 2018

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2018 to June 30, 2018.

ZEALAND PHARMA A/S publishes interim reportMay 17, 2018

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2018 to March 31, 2018.

ZEALAND PHARMA A/S: The 2017 annual report is outApr 20, 2018

ZEALAND PHARMA A/S has published its annual report for 2017. Revenue came to DKK 139,775,000, and the net result was DKK -272,271,000.

Kirsten Aarup Drejer joins the board of ZEALAND PHARMA A/SApr 19, 2018

As of April 19, 2018, Kirsten Aarup Drejer has joined the board of directors of ZEALAND PHARMA A/S.

Helle Haxgart leaves the board of ZEALAND PHARMA A/SApr 10, 2018

As of April 10, 2018, Helle Haxgart has left the board of directors of ZEALAND PHARMA A/S.

Anne Kragh Sager leaves the board of ZEALAND PHARMA A/SApr 10, 2018

As of April 10, 2018, Anne Kragh Sager has left the board of directors of ZEALAND PHARMA A/S.

About ZEALAND PHARMA A/S

ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.

Source: annual report 2025, Danish Business Authority